Jean‐Louis Chiasson

Author

Jean‐Louis Chiasson

Centre Hospitalier de l’Université de Montréal

Also Known As

Jean-Louis Chiasson, Jean‐Louis Chiasson, Jeffrey M. Curtis

104

Publications

13.2K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier de l’Université de Montréal Université de Montréal University of Toronto Hôtel-Dieu de Montréal St. Michael's Hospital

About

Jean‐Louis Chiasson is an author at Centre Hospitalier de l’Université de Montréal specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	28	8K
2	Health Sciences	16	16	3.8K
3	Public Health	10	10	3.8K
4	Language Studies	1	1	84
5	Social Sciences	1	1	202

Jean‐Louis Chiasson

Publications

12.5K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial Jean‐Louis Chiasson, Robert G. Josse, Ramón Gomis, The Lancet Metabolic SyndromeDisease ManagementDiabetes ManagementPreventive MedicineHealth Policy	2002	2.5K
Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance Jean‐Louis Chiasson, Robert G. Josse, Ramón Gomis, JAMA	2003	1.6K
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein Thomas M.S. Wolever, Alison L. Gibbs, Christine C. Mehling, American Journal of Clinical Nutrition Metabolic SyndromeNutritionDiabetes ManagementHealth PolicyDiabetes	2008	332
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan, The Lancet Diabetes & Endocrinology Metabolic SyndromeGlucose ToleranceDiabetes ManagementCardiovascular DiseaseHealth Policy	2017	316
Guidelines for Premeal Insulin Dose Reduction for Postprandial Exercise of Different Intensities and Durations in Type 1 Diabetic Subjects Treated Intensively With a Basal-Bolus Insulin Regimen (Ultralente-Lispro) Rémi Rabasa‐Lhoret, J Bourque, F Ducros, Diabetes Care	2001	300
Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Jean‐Louis Chiasson, Nahla Aris-Jilwan, Raphaël Bélanger, PubMed Diabetic KetoacidosisMetabolic SyndromeHyperglycemic Hyperosmolar StateUrologyInsulin Deficiency	2003	291
Insulin Lispro in CSII: Results of a Double-Blind Crossover Study Bernard Zinman, Hugh D. Tildesley, Jean‐Louis Chiasson, Diabetes	1997	232
Assessment of the Impact of Fear of Hypoglycemic Episodes on Glycemic and Hypoglycemia Management Lawrence A. Leiter, Jean‐François Yale, Jean‐Louis Chiasson, Psychological Co-morbiditiesBehavioral MedicineSocial SciencesHealth PsychologyHypoglycemia Management	2005	202

Page 1